Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125295
Filing Date
2024-11-12
Accepted
2024-11-12 16:00:25
Documents
63
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alvr-20240930.htm   iXBRL 10-Q 2025605
2 EX-31.1 alvr-ex31_1.htm EX-31.1 14981
3 EX-31.2 alvr-ex31_2.htm EX-31.2 16189
4 EX-32.1 alvr-ex32_1.htm EX-32.1 8611
5 EX-32.2 alvr-ex32_2.htm EX-32.2 8649
  Complete submission text file 0000950170-24-125295.txt   6674646

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alvr-20240930.xsd EX-101.SCH 885593
65 EXTRACTED XBRL INSTANCE DOCUMENT alvr-20240930_htm.xml XML 904796
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39409 | Film No.: 241447708
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)